The world's leading legal directory Chambers and Partners recently published its Healthcare M&A Global Practice Guide (2024) (the "Guide"). Han Kun was invited to be the exclusive contributor of the China chapter of the Guide (including the "Law and Practice" and "Trends and Developments" sections). The authors include Aaron Zhou, Ray Shi, Daniel Xu, and Liming Yuan.
The Guide features eleven countries and explores the latest market observations and regulatory developments with respect to M&As in the healthcare sector. The Guide's China chapter covers various aspects of M&As in this salient industry, including market trends, IPO and exit strategies, acquisitions of public companies, spin-offs, regulatory requirements, legal developments, due diligence, data privacy, duties of directors, disclosures, and the establishment of new companies.
Han Kun has a dedicated life sciences and healthcare team and has been consistently ranked as a leading law firm in the life sciences and healthcare sector by authoritative legal directories, including Chambers and Partners, The Legal 500, Asialaw Profiles, and China Business Law Journal. The firm is committed to providing clients in the life sciences and healthcare sector with comprehensive legal services, including private equity and venture capital, mergers and acquisitions, onshore and offshore capital markets, license in/out, asset sale/purchase and other BD transactions, intellectual property, compliance and regulatory, data protection, and dispute resolution.